{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:00:26Z","timestamp":1789902026973,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,1,29]],"date-time":"2006-01-29T00:00:00Z","timestamp":1138492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,1,29]],"date-time":"2006-01-29T00:00:00Z","timestamp":1138492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/nm1363","type":"journal-article","created":{"date-parts":[[2006,1,29]],"date-time":"2006-01-29T18:34:12Z","timestamp":1138559652000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Autoimmunity and tumor immunity induced by immune responses to mutations in self"],"prefix":"10.1038","volume":"12","author":[{"given":"Manuel E","family":"Engelhorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A","family":"Guevara-Pati\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Noffz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea T","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J","family":"Kappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan N","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,1,29]]},"reference":[{"key":"BFnm1363_CR1","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJMra021902","volume":"347","author":"WC Hahn","year":"2002","unstructured":"Hahn, W.C. & Weinberg, R.A. Rules for making human tumor cells. N. Engl. J. Med. 347, 1593\u20131603 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1363_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1084\/jem.186.5.785","volume":"186","author":"S Mandruzzato","year":"1997","unstructured":"Mandruzzato, S., Brasseur, F., Andry, G., Boon, T. & van der Bruggen, P.A. CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med. 186, 785\u2013793 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR3","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1073\/pnas.92.17.7976","volume":"92","author":"PG Coulie","year":"1995","unstructured":"Coulie, P.G. et al. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA 92, 7976\u20137980 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1363_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1084\/jem.183.3.1185","volume":"183","author":"PF Robbins","year":"1996","unstructured":"Robbins, P.F. et al. A mutated \u03b2-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183, 1185\u20131192 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.284.5418.1351","volume":"284","author":"RF Wang","year":"1999","unstructured":"Wang, R.F., Wang, X., Atwood, A.C., Topalian, S.L. & Rosenberg, S.A. Cloning genes encoding MHC class II\u2013restricted antigens: mutated CDC27 as a tumor antigen. Science 284, 1351\u20131354 (1999).","journal-title":"Science"},{"key":"BFnm1363_CR6","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1084\/jem.183.3.1131","volume":"183","author":"RF Wang","year":"1996","unstructured":"Wang, R.F., Parkhurst, M.R., Kawakami, Y., Robbins, P.F. & Rosenberg, S.A. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J. Exp. Med. 183, 1131\u20131140 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<592::AID-IMMU592>3.0.CO;2-2","volume":"29","author":"E Zorn","year":"1999","unstructured":"Zorn, E. & Hercend, T. A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation. Eur. J. Immunol. 29, 592\u2013601 (1999).","journal-title":"Eur. J. Immunol."},{"key":"BFnm1363_CR8","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1126\/science.7652577","volume":"269","author":"T Wolfel","year":"1995","unstructured":"Wolfel, T. et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281\u20131284 (1995).","journal-title":"Science"},{"key":"BFnm1363_CR9","first-page":"5144","volume":"58","author":"KT Hogan","year":"1998","unstructured":"Hogan, K.T. et al. The peptide recognized by HLA-A68.2\u2013restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. Cancer Res. 58, 5144\u20135150 (1998).","journal-title":"Cancer Res."},{"key":"BFnm1363_CR10","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.4049\/jimmunol.162.3.1730","volume":"162","author":"C Gaudin","year":"1999","unstructured":"Gaudin, C., Kremer, F., Angevin, E., Scott, V. & Triebel, F. A hsp70\u20132 mutation recognized by CTL on a human renal cell carcinoma. J. Immunol. 162, 1730\u20131738 (1999).","journal-title":"J. Immunol."},{"key":"BFnm1363_CR11","first-page":"5785","volume":"59","author":"R Chiari","year":"1999","unstructured":"Chiari, R. et al. Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene. Cancer Res. 59, 5785\u20135792 (1999).","journal-title":"Cancer Res."},{"key":"BFnm1363_CR12","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1084\/jem.183.6.2501","volume":"183","author":"D Brandle","year":"1996","unstructured":"Brandle, D., Brasseur, F., Weynants, P., Boon, T. & Van den Eynde, B. A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma. J. Exp. Med. 183, 2501\u20132508 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR13","first-page":"769","volume":"18","author":"RT Prehn","year":"1957","unstructured":"Prehn, R.T. & Main, J.M. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18, 769\u2013778 (1957).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFnm1363_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1073\/pnas.74.1.272","volume":"74","author":"T Boon","year":"1977","unstructured":"Boon, T. & Kellermann, O. Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc. Natl. Acad. Sci. USA 74, 272\u2013275 (1977).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1363_CR15","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1073\/pnas.75.3.1519","volume":"75","author":"T Boon","year":"1978","unstructured":"Boon, T. & Van Pel, A. Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line. Proc. Natl. Acad. Sci. USA 75, 1519\u20131523 (1978).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1363_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1074-7613(00)00052-2","volume":"13","author":"EJ Slansky","year":"2000","unstructured":"Slansky, E.J. et al. Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity 13, 529\u2013538 (2000).","journal-title":"Immunity"},{"key":"BFnm1363_CR17","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.188.9.1553","volume":"188","author":"R Dyall","year":"1998","unstructured":"Dyall, R. et al. Heteroclitic immunization induces tumor immunity. J. Exp. Med. 188, 1553\u20131561 (1998).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR18","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.4049\/jimmunol.170.10.5188","volume":"170","author":"JS Gold","year":"2003","unstructured":"Gold, J.S. et al. A single heteroclitic epitope determines cancer immunity following xenogeneic DNA immunization against a tumor differentiation antigen. J. Immunol. 170, 5188\u20135194 (2003).","journal-title":"J. Immunol."},{"key":"BFnm1363_CR19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4049\/jimmunol.95.2.378","volume":"95","author":"O Makela","year":"1965","unstructured":"Makela, O. Single lymph node cells producing heteroclitic bacteriophage antibody. J. Immunol. 95, 378\u2013386 (1965).","journal-title":"J. Immunol."},{"key":"BFnm1363_CR20","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1172\/JCI4004","volume":"102","author":"LW Weber","year":"1998","unstructured":"Weber, L.W. et al. Tumor immunity and autoimmunity induced by immunization with homologous DNA. J. Clin. Invest. 102, 1258\u20131264 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnm1363_CR21","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.190.11.1717","volume":"190","author":"WB Bowne","year":"1999","unstructured":"Bowne, W.B. et al. Coupling and uncoupling of tumor immunity and autoimmunity. J. Exp. Med. 190, 1717\u20131722 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm813","volume":"9","author":"WW Leitner","year":"2003","unstructured":"Leitner, W.W. et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9, 33\u201339 (2003).","journal-title":"Nat. Med."},{"key":"BFnm1363_CR23","doi-asserted-by":"publisher","first-page":"S136","DOI":"10.1101\/gr.3.6.S136","volume":"3","author":"RC Cadwell","year":"1994","unstructured":"Cadwell, R.C. & Joyce, G.F. Mutagenic PCR. PCR Methods Appl. 3, S136\u2013S140 (1994).","journal-title":"PCR Methods Appl."},{"key":"BFnm1363_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/377632a0","volume":"377","author":"MA Barry","year":"1995","unstructured":"Barry, M.A., Lai, W.C. & Johnston, S.A. Protection against mycoplasma infection using expression-library immunization. Nature 377, 632\u2013635 (1995).","journal-title":"Nature"},{"key":"BFnm1363_CR25","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/nar\/14.6.2413","volume":"14","author":"S Shibahara","year":"1986","unstructured":"Shibahara, S. et al. Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res. 14, 2413\u20132427 (1986).","journal-title":"Nucleic Acids Res."},{"key":"BFnm1363_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/j.1460-2075.1992.tb05083.x","volume":"11","author":"IJ Jackson","year":"1992","unstructured":"Jackson, I.J. et al. A second tyrosinase-related protein, TRP-2, maps to and is mutated at the mouse slaty locus. EMBO J. 11, 527\u2013535 (1992).","journal-title":"EMBO J."},{"key":"BFnm1363_CR27","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1084\/jem.182.5.1609","volume":"182","author":"I Hara","year":"1995","unstructured":"Hara, I., Takechi, Y. & Houghton, A.N. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J. Exp. Med. 182, 1609\u20131614 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR28","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","volume":"96","author":"WW Overwijk","year":"1999","unstructured":"Overwijk, W.W. et al. Vaccination with a recombinant vaccinia virus encoding a 'self' antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA 96, 2982\u20132987 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1363_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1034\/j.1600-065X.2002.18811.x","volume":"188","author":"MJ Turk","year":"2002","unstructured":"Turk, M.J., Wolchok, J.D., Guevara-Patino, J.A., Goldberg, S.M. & Houghton, A.N. Multiple pathways to tumor immunity and concomitant autoimmunity. Immunol. Rev. 188, 122\u2013135 (2002).","journal-title":"Immunol. Rev."},{"key":"BFnm1363_CR30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1172\/JCI4004","volume":"102","author":"LW Weber","year":"1998","unstructured":"Weber, L.W. et al. Tumor immunity and autoimmunity induced by immunization with homologous DNA. J. Clin. Invest. 102, 1258\u20131264 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnm1363_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature02240","volume":"427","author":"K Hanada","year":"2004","unstructured":"Hanada, K., Yewdell, J.W. & Yang, J.C. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427, 252\u2013256 (2004).","journal-title":"Nature"},{"key":"BFnm1363_CR32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1126\/science.1095522","volume":"304","author":"N Vigneron","year":"2004","unstructured":"Vigneron, N. et al. An antigenic peptide produced by peptide splicing in the proteasome. Science 304, 587\u2013590 (2004).","journal-title":"Science"},{"key":"BFnm1363_CR33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bbrc.2005.01.040","volume":"328","author":"G Negroiu","year":"2005","unstructured":"Negroiu, G., Dwek, R.A. & Petrescu, S.M. Tyrosinase-related protein-2 and -1 are trafficked on distinct routes in B16 melanoma cells. Biochem. Biophys. Res. Commun. 328, 914\u2013921 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnm1363_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0022-2836(02)01437-7","volume":"326","author":"Y Zhu","year":"2003","unstructured":"Zhu, Y., Rudensky, A.Y., Corper, A.L., Teyton, L. & Wilson, I.A. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. J. Mol. Biol. 326, 1157\u20131174 (2003).","journal-title":"J. Mol. Biol."},{"key":"BFnm1363_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1084\/jem.175.6.1423","volume":"175","author":"NP Restifo","year":"1992","unstructured":"Restifo, N.P., Spiess, P.J., Karp, S.E., Mule, J.J. & Rosenberg, S.A. A nonimmunogenic sarcoma transduced with the cDNA for interferon \u03b3 elicits CD8+ T cells against the wild-type tumor: Correlation with antigen presentation capability. J. Exp. Med. 175, 1423\u20131431 (1992).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.190.11.1717","volume":"190","author":"WB Bowne","year":"1999","unstructured":"Bowne, W.B. et al. Coupling and uncoupling of tumor immunity and autoimmunity. J. Exp. Med. 190, 1717\u20131722 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm1363_CR37","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1073\/pnas.94.10.5332","volume":"94","author":"N Le Fur","year":"1997","unstructured":"Le Fur, N., Kelsall, S.R., Silvers, W.K. & Mintz, B. Selective increase in specific alternative splice variants of tyrosinase in murine melanomas: a projected basis for immunotherapy. Proc. Natl. Acad. Sci. USA 94, 5332\u20135337 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm1363_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nmeth719","volume":"1","author":"A Watahiki","year":"2004","unstructured":"Watahiki, A. et al. Libraries enriched for alternatively spliced exons reveal splicing patterns in melanocytes and melanomas. Nat. Methods 1, 233\u2013239 (2004).","journal-title":"Nat. Methods"},{"key":"BFnm1363_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/nar\/gkg070","volume":"31","author":"J Robinson","year":"2003","unstructured":"Robinson, J. et al. IMGT\/HLA and IMGT\/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31, 311\u2013314 (2003).","journal-title":"Nucleic Acids Res."},{"key":"BFnm1363_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0889-8561(02)00055-3","volume":"23","author":"RB Effros","year":"2003","unstructured":"Effros, R.B. Problems and solutions to the development of vaccines in the elderly. Immunol. Allergy Clin. North Am. 23, 41\u201355 (2003).","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"BFnm1363_CR41","first-page":"2191","volume":"3","author":"HM Ross","year":"1997","unstructured":"Ross, H.M. et al. Priming for T-cell-mediated rejection of established tumors by cutaneous DNA immunization. Clin. Cancer Res. 3, 2191\u20132196 (1997).","journal-title":"Clin. Cancer Res."},{"key":"BFnm1363_CR42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/1097-0215(20000801)87:3<391::AID-IJC13>3.0.CO;2-K","volume":"87","author":"JJ Lewis","year":"2000","unstructured":"Lewis, J.J. et al. Evaluation of CD8+ T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. Int. J. Cancer 87, 391\u2013398 (2000).","journal-title":"Int. J. Cancer"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1363","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1363.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T13:36:15Z","timestamp":1744292175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,29]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BFnm1363"],"URL":"https:\/\/doi.org\/10.1038\/nm1363","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,29]]},"assertion":[{"value":"14 October 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}